Literature DB >> 2645947

Indications for marrow transplantation in chronic myelogenous leukemia.

E D Thomas1, R A Clift.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2645947

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

Review 1.  Haematology.

Authors:  N T O'Connor
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

Review 2.  Graft versus leukemia.

Authors:  A Butturini; R P Gale
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 3.  Treatment of chronic myelogenous leukaemia.

Authors:  B Simonsson
Journal:  Med Oncol       Date:  1998-04       Impact factor: 3.064

Review 4.  An overview of bone marrow transplantation for chronic myeloid leukemia.

Authors:  M J Barnett; A C Eaves; G L Phillips
Journal:  CMAJ       Date:  1990-08-01       Impact factor: 8.262

5.  Allogeneic stem cell transplantation for chronic myeloid leukemia resistant to tyrosine kinase inhibitors.

Authors:  Richard Champlin; Elias Jabbour; Partow Kebriaei; Paolo Anderlini; Borje Andersson; Marcos de Lima
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-04-28

Review 6.  Allogeneic marrow transplantation for chronic myeloid leukemia.

Authors:  F R Applebaum; R Clift; C D Buckner; C Anasetti; J Radich; T Higano; R Storb; J Hansen; E D Thomas
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

Review 7.  Interferon in chronic myeloid leukemia. A workshop report.

Authors:  M Griesshammer; R Hehlmann; A Hochhaus; M Talpaz; S Tura; P Stryckmans; N C Allan; J Tanzer; H J Kolb; H Heimpel
Journal:  Ann Hematol       Date:  1993-08       Impact factor: 3.673

8.  Apparent decrease and elimination of BCR/ABL mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow transplantation.

Authors:  W Lange; R Herkert; J Finke; U Ragoczy; W Siegert; R Mertelsmann; G Dölken
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

9.  Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-alpha-treated chronic myelogenous leukaemia patients.

Authors:  G Pawelec; G Ehninger; H Schmidt; C Müller; H J Bühring; M Reutter; F W Busch
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

10.  Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation.

Authors:  D P Agaliotis; P R Papenhausen; L C Moscinski; G J Elfenbein
Journal:  Ann Hematol       Date:  1995-01       Impact factor: 3.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.